Fundz
Funding, M&A and exec moves matched to your market, guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Sfa Therapeutics Appoints Shawn Patrick O'brien As CEO and Dr. Ira C. Spector As Chief Strategy Officer

PRIVATEAug 19, 2026•about 7 hours ago

Position

Chief Strategy Officer

Company

SFA Therapeutics

Ira C. Spector
JenkintownBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

SFA Therapeutics announces the appointment of Shawn Patrick O'Brien as CEO, taking over from Dr. Ira C. Spector, who moves to Chief Strategy Officer

Company Information

Company

SFA Therapeutics

Location

Jenkintown, Pennsylvania, United States

About

SFA Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for the treatment of inflammatory diseases. Based on breakthrough research licensed from Temple University, SFA Therapeutics' platform has the potential to develop safer and more efficacious treatments for a number of chronic inflammatory diseases by uniquely tailoring the effects of patented formulations with target-specific adjuvants.

Don't miss SFA Therapeutics's next move

Get an email the moment SFA Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Stefan
Likely contact at this company
••••••••@••••••••

See Stefan's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for SFA Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

SFA Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.